HK1251455A1 - 聚糖治療劑和治療方法 - Google Patents

聚糖治療劑和治療方法

Info

Publication number
HK1251455A1
HK1251455A1 HK18110824.1A HK18110824A HK1251455A1 HK 1251455 A1 HK1251455 A1 HK 1251455A1 HK 18110824 A HK18110824 A HK 18110824A HK 1251455 A1 HK1251455 A1 HK 1251455A1
Authority
HK
Hong Kong
Prior art keywords
treatment
methods
glycan therapeutics
glycan
therapeutics
Prior art date
Application number
HK18110824.1A
Other languages
English (en)
Inventor
Maltzahn Geoffrey A Von
Yvonne J Yamanaka
Jared Silverman
Jack Milwid
Jacob R Rubens
John M Geremia
Original Assignee
Kaleido Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaleido Biosciences Inc filed Critical Kaleido Biosciences Inc
Publication of HK1251455A1 publication Critical patent/HK1251455A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK18110824.1A 2015-04-23 2018-08-22 聚糖治療劑和治療方法 HK1251455A1 (zh)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201562152017P 2015-04-23 2015-04-23
US201562152007P 2015-04-23 2015-04-23
US201562152011P 2015-04-23 2015-04-23
US201562216997P 2015-09-10 2015-09-10
US201562216995P 2015-09-10 2015-09-10
US201562238112P 2015-10-06 2015-10-06
US201562238110P 2015-10-06 2015-10-06
US201662278333P 2016-01-13 2016-01-13
PCT/US2016/029082 WO2016172657A2 (en) 2015-04-23 2016-04-23 Glycan therapeutics and methods of treatment

Publications (1)

Publication Number Publication Date
HK1251455A1 true HK1251455A1 (zh) 2019-02-01

Family

ID=55967431

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18110824.1A HK1251455A1 (zh) 2015-04-23 2018-08-22 聚糖治療劑和治療方法

Country Status (12)

Country Link
US (4) US20180147221A1 (zh)
EP (2) EP3964234A1 (zh)
JP (2) JP2018517677A (zh)
CN (2) CN107771083A (zh)
AU (2) AU2016253010B2 (zh)
CA (1) CA2983236A1 (zh)
DK (1) DK3285777T3 (zh)
ES (1) ES2895725T3 (zh)
HK (1) HK1251455A1 (zh)
LT (1) LT3285777T (zh)
SI (1) SI3285777T1 (zh)
WO (1) WO2016172657A2 (zh)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3228950A1 (en) 2014-07-09 2016-01-14 Dsm Nutritional Products, Llc Oligosaccharide compositions and methods for producing thereof
BR112017015944B1 (pt) 2015-01-26 2022-03-22 Cadena Bio, Inc Composição de ração animal, pré-mistura de ração animal, uso e método para produzir uma composição de ração animal
DK3354282T3 (da) 2015-01-26 2021-03-08 Kaleido Biosciences Inc Glycan-terapeutiske midler og relaterede fremgangsmåder deraf
AU2016253010B2 (en) 2015-04-23 2021-06-10 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
EP3907285A1 (en) 2015-05-06 2021-11-10 Snipr Technologies Limited Altering microbial populations & modifying microbiota
MX2018002990A (es) * 2015-09-10 2018-06-08 Univ Catholique Louvain Uso de la akkermansia pasteurizada para tratar trastornos metabolicos.
GB201609811D0 (en) * 2016-06-05 2016-07-20 Snipr Technologies Ltd Methods, cells, systems, arrays, RNA and kits
CN109689067A (zh) 2016-07-13 2019-04-26 卡莱多生物科技有限公司 聚糖组合物和使用方法
TWI673056B (zh) * 2016-07-22 2019-10-01 大江生醫股份有限公司 包含細菌的水凝膠及其製備方法
EP3551194B1 (en) * 2016-12-06 2023-10-18 DSM Nutritional Products, LLC Glycan polymers and related methods thereof
WO2018145082A1 (en) * 2017-02-06 2018-08-09 New York University Methods and compositions for treating and diagnosing pancreatic cancers
EP3606346B1 (en) 2017-04-07 2023-08-30 The Trustees of Columbia University in the City of New York Oral antimicrobial or antiseptic rinse for use in treating or preventing barrett's oesophagus
EP3638816A1 (en) * 2017-06-12 2020-04-22 Debreceni Egyetem Methods for diagnosing breast cancer
BR112019028301A2 (pt) * 2017-07-05 2020-07-14 Evelo Biosciences, Inc. composições e métodos para tratar câncer com o uso de bifidobacterium animalis ssp. lactis
JP2020526541A (ja) * 2017-07-13 2020-08-31 カレイド・バイオサイエンシズ・インコーポレイテッド グリカン組成物及び使用方法
CN111328284A (zh) * 2017-08-07 2020-06-23 芬奇治疗公司 用于维持和恢复健康的肠道屏障的组合物和方法
WO2019090182A2 (en) 2017-11-03 2019-05-09 Kaleido Biosciences, Inc. Glycan preparations and methods of use for hyperammonemia
JP2021502338A (ja) * 2017-11-03 2021-01-28 カレイド・バイオサイエンシズ・インコーポレイテッド 感染の治療のためのグリカン調製物
WO2019090181A1 (en) 2017-11-03 2019-05-09 Kaleido Biosciences, Inc. Methods of producing glycan polymers
JP2021502964A (ja) 2017-11-14 2021-02-04 エヴェロ バイオサイエンシズ，インコーポレーテッド ブラウティア（Ｂｌａｕｔｉａ）株を使用して疾患を処置するための組成物及び方法
KR102282490B1 (ko) 2018-01-12 2021-07-28 주식회사 엠디헬스케어 패칼리박테리움 프라우스니찌 유래 나노소포 및 이의 용도
AU2019230061A1 (en) * 2018-03-09 2020-09-24 Nutrition & Biosciences USA 4, Inc. Engineered glucosyltransferases
US10760075B2 (en) 2018-04-30 2020-09-01 Snipr Biome Aps Treating and preventing microbial infections
CN108653341B (zh) * 2018-05-30 2021-04-30 华中科技大学 一种用于恶性肿瘤免疫治疗的药盒及其应用
IT201800006815A1 (it) * 2018-06-29 2019-12-29 An organic-inorganic hybrid material comprising a metal and lignin, processes for preparing the same and uses thereof / materiale ibrido organico-inorganico comprendente metallo e lignina, processi per la sua preparazione e suoi usi
CN109022317B (zh) * 2018-08-15 2022-04-05 河南金百合生物科技股份有限公司 一种丁酸梭菌菌粉的制备方法
JP2022506635A (ja) * 2018-11-08 2022-01-17 カレイド・バイオサイエンシズ・インコーポレイテッド オリゴ糖組成物およびその使用方法
KR20210141541A (ko) * 2019-03-11 2021-11-23 와이소피아 바이오사이언시즈 만성 염증성 질환 및/또는 염증성 위장 질환 및/또는 암의 예방 및/또는 치료를 위한 크리스텐세넬라시아에 과의 박테리아
WO2021041981A1 (en) 2019-08-28 2021-03-04 Assembly Biosciences, Inc. Compositions comprising bacterial species and methods related thereto
CN110592056A (zh) * 2019-09-19 2019-12-20 昆明理工大学 噬菌体裂解酶复合粉剂及其制备方法和应用
CA3151747A1 (en) * 2019-09-23 2021-04-01 James J. MOON Compositions and methods for increasing the efficacy of immunotherapies and vaccines
WO2021087072A1 (en) * 2019-10-29 2021-05-06 Mohapatra Shyam S Compositions and methods for preventing and treating respiratory syncytial virus infection
JP2023503542A (ja) * 2019-11-27 2023-01-31 ディーエスエム アイピー アセッツ ビー．ブイ． リボフラビンを含むｍｕｐｓ錠剤
CN110787171A (zh) * 2019-12-11 2020-02-14 浙江华康药业股份有限公司 槐糖在预防和治疗炎症性肠病产品中的应用及对应产品
CN110946871A (zh) * 2019-12-12 2020-04-03 浙江华康药业股份有限公司 槐糖在制备预防和治疗肥胖产品中的应用及对应产品
CN111603500B (zh) * 2020-06-30 2022-03-04 河南中大恒源生物科技股份有限公司 一种决明子提取物及决明子综合开发利用的工艺技术
CN116113404A (zh) * 2020-07-17 2023-05-12 Dsm营养产品有限责任公司 寡糖组合物及其使用方法
KR20230076828A (ko) * 2020-09-25 2023-05-31 디에스엠 뉴트리셔널 프로덕츠, 엘엘씨 올리고사카라이드 조성물 및 사용 방법
US20240309408A1 (en) * 2021-05-13 2024-09-19 Bcd Bioscience, Inc. Methods of Use of Oligosaccharide Compositions for Modulating Microbiota and their Metabolic Products, and as Therapeutics for Health Applications
CN114381406B (zh) * 2022-01-27 2023-06-13 江南大学 可同时降低血浆及盲肠三甲胺的短双歧杆菌ccfm1217及其应用
US11759434B2 (en) * 2022-02-03 2023-09-19 Sytheon Limited Methods and compositions for treating melanoma and non-melanoma skin cancers
WO2023148525A1 (en) * 2022-02-04 2023-08-10 Health And Happiness (H&H) Hong Kong Ltd 2'-fucosyllactose and lacto-n-neotetraose for preventing and treating overweight
CN114452305B (zh) * 2022-03-17 2024-07-26 北京航空航天大学 单形拟杆菌用于制造预防与治疗焦虑抑郁症药物中的应用
CN114788837B (zh) * 2022-06-07 2023-09-05 青岛东海药业有限公司 一种组合物及其在制备治疗和/或预防化疗引起的恶心呕吐的药物中的应用
GB202209518D0 (en) 2022-06-29 2022-08-10 Snipr Biome Aps Treating & preventing E coli infections
WO2024006539A1 (en) * 2022-07-01 2024-01-04 Vitakey Inc. Nutraceutical particles
WO2024144751A1 (en) * 2022-12-31 2024-07-04 Si̇lver Shell Sağlik Ürünleri̇ Anoni̇m Şi̇rketi̇ Ahcc characterization for use in different forms and related method

Family Cites Families (131)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2027904A (en) 1933-02-16 1936-01-14 Int Suiker En Alcohol Cie Inte Method of polymerizing monosaccharides
US2436967A (en) 1942-04-01 1948-03-02 Corn Prod Refining Co Polymerization of sugars
US2719179A (en) 1951-01-25 1955-09-27 Mora Peter Tibor Branched-chain carbohydrate polymers and their preparation
US3766165A (en) 1966-08-17 1973-10-16 Pfizer Polysaccharides and their preparation
US3876794A (en) 1972-12-20 1975-04-08 Pfizer Dietetic foods
US3973049A (en) 1974-03-14 1976-08-03 General Foods Corporation Method of mixing flavors and fixed composition comprising derivatized synthetic polysaccharides
US4671967A (en) 1984-05-18 1987-06-09 Wm. Wrigley Jr. Company Carbohydrate syrups and methods of preparation
GB8519416D0 (en) 1985-08-01 1985-09-04 Unilever Plc Oligosaccharides
US4965354A (en) 1988-02-26 1990-10-23 Taito Company, Ltd. Process for producing a condensed polysaccharide
US4927811A (en) 1988-11-15 1990-05-22 Coors Biotech, Inc. Method and composition for improved animal husbandry
US5667593A (en) 1989-01-26 1997-09-16 Cultor Ltd. Modified polydextrose and process therefor
US5051500A (en) 1989-08-11 1991-09-24 A. E. Staley Manufacturing Company Method of preparing a randomly-bonded polysaccharide
US5397863A (en) 1991-09-13 1995-03-14 International Business Machines Corporation Fluorinated carbon polymer composites
AU659896B2 (en) 1991-12-27 1995-06-01 Matsutani Chemical Industries Co., Ltd. Feed for livestock which contains galacto-oligosaccharides
JPH06121693A (ja) 1992-08-25 1994-05-06 Akebono Brake Res & Dev Center Ltd 高重合度オリゴ糖の製造法
FR2697023B1 (fr) 1992-10-16 1994-12-30 Roquette Freres Polymère soluble hypocalorique du glucose et procédé de préparation de ce polymère .
JPH0770165A (ja) 1993-06-28 1995-03-14 Hayashibara Biochem Lab Inc 非還元性オリゴ糖とその製造方法並びに用途
BR9407612A (pt) 1993-09-24 1997-01-14 Procter & Gamble Novos compostos de 14-aminoesteróides contendo oligossacarideos e nova química de processo de aminoesteróide diastereosseletivo
FR2712891B1 (fr) 1993-11-22 1996-02-02 Roquette Freres Procédé de purification d'un polymère soluble hypocalorique du glucose et produit ainsi obtenu.
NL9400040A (nl) 1994-01-10 1995-08-01 Suiker Unie Werkwijze voor het bereiden van polysaccharidederivaten.
US5843922A (en) 1994-07-29 1998-12-01 Fuisz Technologies Ltd. Preparation of oligosaccharides and products therefrom
JP3413062B2 (ja) 1996-06-19 2003-06-03 キヤノン株式会社 糖鎖高分子化合物を含む高分子化合物及びその分解方法
WO1998041544A1 (en) 1997-03-19 1998-09-24 Cultor Food Science, Inc. Polymerization of mono- and disaccharides using low levels of polycarboxylic acids
US6475552B1 (en) 1997-03-19 2002-11-05 Danisco Finland Oy Polymerization of mono and disaccharides using low levels of polycarboxylic acids
CA2284911C (en) 1997-03-19 2006-10-24 Cultor Food Science, Inc. Polymerization of mono-and disaccharides using low levels of mineral acids
AUPO888497A0 (en) 1997-09-01 1997-09-25 Australian National University, The Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
US6423833B1 (en) 1998-05-05 2002-07-23 Steven J. Catani Functional sugar polymers from inexpensive sugar sources and apparatus for preparing same
FR2786775B1 (fr) 1998-12-04 2001-02-16 Roquette Freres Maltodextrines branchees et leur procede de preparation
DE19860376A1 (de) 1998-12-28 2000-07-06 Aventis Res & Tech Gmbh & Co Alpha-1,4 Glucanketten enthaltende Polysaccharide sowie Verfahren zu ihrer Herstellung
US6977245B2 (en) 1999-04-12 2005-12-20 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxynucleotide and its use to induce an immune response
JP2001086999A (ja) * 1999-09-22 2001-04-03 Oji Paper Co Ltd キシロオリゴ糖含有組成物およびガン細胞アポトーシス誘導剤
CA2391966A1 (en) 1999-11-24 2001-05-31 Massachusetts Institute Of Technology Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries
DE19961182B4 (de) 1999-12-18 2006-01-12 Südzucker AG Mannheim/Ochsenfurt Galactomannan-Oligosaccharide und Verfahren zu deren Herstellung sowie deren Verwendung
US7608291B2 (en) 2000-03-10 2009-10-27 Mars, Inc. Treatment of infection in animals
ATE361678T1 (de) 2000-12-27 2007-06-15 Nutricia Nv Ernährungszusammensetzung mit gesundheitsfördernder wirkung enthaltend oligosaccharide
DE10147100A1 (de) * 2001-09-25 2003-04-17 Numico Res B V Antiinfektive Kohlenhydrate
NZ515869A (en) 2001-11-30 2003-09-26 Med Chem Ingredients Ltd Compositions and methods for animal treatment comprising gluco- and isomalto- oligosaccharides
KR20030069454A (ko) 2002-02-20 2003-08-27 주식회사한국신약 펠리누스 린테우스에서 추출한 다당류와5-플루오로우라실을 포함하는 복합 항암제
WO2003104473A2 (de) 2002-06-07 2003-12-18 Südzucker Aktiengesellschaft Galactosyl-isomalt, verfahren zu seiner herstellung und verwendung
EP1531832B1 (en) 2002-06-28 2009-04-15 Glykos Finland Oy Therapeutic compositions for use in prophylaxis or treatment of diarrheas
NZ538439A (en) 2002-07-23 2007-02-23 Neose Technologies Inc Synthesis of oligosaccharides, glycolipids, and glycoproteins using bacterial glycosyltransferases
CN100532557C (zh) 2002-08-23 2009-08-26 纳幕尔杜邦公司 淀粉制品在利用发酵的生物生产中的应用
US20040052915A1 (en) 2002-09-13 2004-03-18 Carlson Ting L. Use of low glycemic index sweeteners in food and beverage compositions
JPWO2004026341A1 (ja) * 2002-09-19 2006-01-12 株式会社オリエントキャンサーセラピー ガンの免疫治療剤
FI20021772A (fi) 2002-10-04 2004-04-05 Biotie Therapies Oyj Uudet hiilihydraattikoostumukset ja menetelmä niiden valmistamiseksi
JP3899462B2 (ja) * 2002-12-02 2007-03-28 独立行政法人農業・食品産業技術総合研究機構 ガン細胞アポトーシス誘導剤
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
CA2467695C (en) * 2003-05-20 2010-03-16 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Isomaltooligosaccharides from leuconostoc as neutraceuticals
EP1626053B1 (en) 2003-05-22 2011-07-06 Japan Science and Technology Agency Method of alpha-selective glycosylation
RU2313572C2 (ru) 2003-06-30 2007-12-27 Класадо Инк. Штамм bifidobacterium bifidum, обладающий галактозидазной активностью, галактоолигосахаридная композиция для стимуляции роста бифидобактерий, синбиотическая композиция для улучшения состояния кишечника, их применение (варианты) для получения лекарственных препаратов и способ получения стимулятора роста бифидобактерий
JP4597630B2 (ja) 2003-10-29 2010-12-15 株式会社神戸製鋼所 表面処理方法及び装置
CN1562050A (zh) 2004-03-24 2005-01-12 中国海洋大学 褐藻酸寡糖在抗痴呆、抗糖尿病中的应用
EP1634599A1 (en) * 2004-08-20 2006-03-15 N.V. Nutricia Iimmune stimulatory infant nutrition
FR2874825B1 (fr) 2004-09-08 2006-12-08 Genibio Sarl Utilisations d'oligosaccharides prebiotiques benefiques pour la flore vaginale
US20060093592A1 (en) 2004-10-04 2006-05-04 Nutracea Synbiotics
CN1255041C (zh) 2004-10-27 2006-05-10 李向群 一种甲壳胺饲料添加剂的制备方法
DE102004058811A1 (de) 2004-12-07 2006-06-08 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Herstellung von Zuckeralkoholen
WO2007010084A2 (en) * 2005-07-15 2007-01-25 Johannes Savolainen Immunostimulatory oligo- and polysaccharides and uses thereof
WO2007015932A1 (en) 2005-07-27 2007-02-08 Cantabria Group Lcc Phosphorylated glucomannane polysaccharides containing 1-6 and 1-2 linkages increase weight gain in poultry
MX2008002487A (es) 2005-08-25 2008-04-03 Adm Alliance Nutrition Inc Uso de dextrina en alimento para animales.
DK1940243T3 (da) 2005-10-24 2011-11-14 Nestec Sa Kostfiberformulering og fremgangsmåde til indgivelse
ES2332149T3 (es) 2005-12-16 2010-01-27 N.V. Nutricia Composicion comprendiendo oligosacaridos en forma de fibras dieteticas solubles para su uso contra la atrofia muscular.
US8057840B2 (en) 2006-01-25 2011-11-15 Tate & Lyle Ingredients Americas Llc Food products comprising a slowly digestible or digestion resistant carbohydrate composition
US7608436B2 (en) 2006-01-25 2009-10-27 Tate & Lyle Ingredients Americas, Inc. Process for producing saccharide oligomers
US8993039B2 (en) 2006-01-25 2015-03-31 Tate & Lyle Ingredients Americas Llc Fiber-containing carbohydrate composition
FR2897869B1 (fr) 2006-02-28 2011-05-06 Roquette Freres Polymeres solubles de glucose hautement branches pour la nutrition enterale, parenterale et pour la dialyse peritoneale
US7915235B2 (en) 2006-03-20 2011-03-29 Brian Dieckgraefe High affinity ligands bind to clostridium difficile toxin A
CA2646021A1 (en) 2006-04-05 2007-10-05 Oklahoma Medical Research Foundation O-glycans in the treatment of inflammatory bowel disease and cancers
WO2007117175A1 (en) 2006-04-10 2007-10-18 Avva Pharmaceuticals Ag Pharmaceutical composition of enterosorbent and prebiotics, dosage forms, and the method for prevention and treatment of gastrointestinal disorders
EP1887017A1 (en) 2006-08-09 2008-02-13 Friesland Brands B.V. Prebiotic carbohydrate
US20080069861A1 (en) * 2006-09-19 2008-03-20 National Starch And Chemical Investment Holding Corporation Probiotic/Non-Probiotic Combinations
FI20065593L (fi) 2006-09-26 2008-03-27 Valio Oy Menetelmä galakto-oligosakkarideja sisältävien tuotteiden valmistamiseksi ja niiden käyttö
KR20080047957A (ko) 2006-11-27 2008-05-30 주식회사 엠디바이오알파 고혈압의 치료 및 예방을 위한 약제 조성물
US20130216693A1 (en) 2007-01-24 2013-08-22 Tate & Lyle Ingredients Americas Llc Fiber-containing carbohydrate composition
ES2304223B2 (es) 2007-03-08 2009-05-01 Universidad De Sevilla Nuevos caramelos con elevado contenido en oligosacaridos prebioticos, procedimiento de preparacion y utilizacion.
US8197872B2 (en) 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
WO2008156354A1 (en) * 2007-06-21 2008-12-24 N.V. Nutricia Modulation of intestinal flora of hiv patients
EP2160377A1 (en) 2007-06-29 2010-03-10 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Targeting diazo prodrugs for the treatment of gastrointestinal diseases
ES2337510T3 (es) 2007-07-13 2010-04-26 Stryker Trauma Gmbh Pieza manual ultrasonica.
AU2008318343B2 (en) * 2007-11-02 2013-07-18 Dilafor Ab Non-anticoagulant polysaccharide compositions
EP2234505B1 (en) 2007-12-21 2013-01-30 N.V. Nutricia Use of sphingomyelin and non-digestible carbohydrates for improving intestinal microbiota
ITBA20080008A1 (it) 2008-02-22 2009-08-23 Michele Barone Composizioni comprendenti fitoestrogeni selettivi per il recettore estrogenico beta e fibre dietetiche
WO2009152089A2 (en) 2008-06-09 2009-12-17 Temple-Inland Prebiotic composition and methods of making and using the same
EP2355670B1 (en) 2008-12-10 2013-03-27 Katholieke Universiteit Leuven Nutriment containing arabinoxylan and oligosaccharides
EP2405918B2 (en) 2009-03-13 2020-09-02 The Regents of The University of California Prebiotic oligosaccharides
JP6077303B2 (ja) 2009-05-07 2017-02-08 タト エ リル アングルディアント フランス ソシエテ パ アクシオンス シンプリフィエ アルファ−（１，２）−分岐アルファ−（１，６）オリゴデキストランを含有する組成物及びアルファ−（１，２）−分岐アルファ−（１，６）オリゴデキストランの製造方法
EP2248907A1 (en) 2009-05-08 2010-11-10 Rijksuniversiteit Groningen Gluco-oligosaccharides comprising (alpha 1-->4) and (alpha 1-->6) glycosidic bonds, use thereof, and methods for providing them
UA104469C2 (uk) 2009-05-27 2014-02-10 Класадо Інк. Спосіб запобігання діареї мандрівників
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
MY189329A (en) * 2009-07-15 2022-02-04 Nutricia Nv Mixture of non-digestible oligosaccharides for stimulating the immune system
US8691792B2 (en) 2009-08-05 2014-04-08 Nestec Sa Methods and compositions for improving gastrointetinal health
DE102010025323A1 (de) 2010-02-19 2011-08-25 Krüger GmbH & Co. KG, 51469 Neue Süßstoffzusammensetzungen
DE102010012282A1 (de) 2010-03-22 2011-09-22 Fresenius Medical Care Deutschland Gmbh Pharmazeutische Zusammensetzung enthaltend Cyclodextrin-Copolymer
BE1019290A5 (nl) 2010-04-14 2012-05-08 Nutrition Sciences Nv Sa Voedingsupplement omvattende oligosachariden en middellange keten vetzuren.
CN103201395B (zh) 2010-06-26 2016-03-02 威尔迪亚有限公司 糖混合物及其生产和使用方法
EP2401925B1 (fr) 2010-06-29 2014-05-07 Rosebud AG Produit prebiotique et procede de fabrication
US20120034366A1 (en) 2010-08-05 2012-02-09 Tate & Lyle Ingredients Americas, Inc. Carbohydrate compositions
EP2465507A1 (en) 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
JP2012158526A (ja) 2011-01-31 2012-08-23 Niigata Institute Of Science & Technology Niigata Univ Of Pharmacy & Applied Life Sciences マンノオリゴ糖の製造法
US20140187474A1 (en) 2011-02-16 2014-07-03 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic use of mucin glycans
SG192958A1 (en) 2011-02-28 2013-09-30 Midori Renewables Inc Polymeric acid catalysts and uses thereof
US9234225B2 (en) 2011-05-13 2016-01-12 Glycom A/S Method for generating human milk oligosaccharides (HMOs) or precursors thereof
JP5877902B2 (ja) 2011-08-17 2016-03-08 マイクロバイオーム セラピューティクス，エルエルシー バクテロイデス門の胃腸管微生物相対フィルミクテス門の微生物相の比を上昇させるための組成物および製剤の使用
US20150087616A1 (en) 2011-11-30 2015-03-26 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
FR2987360B1 (fr) 2012-02-28 2014-03-28 Roquette Freres Maltodextrines hyperbranchees hypo-glycemiantes
EP2666788A1 (en) 2012-05-21 2013-11-27 Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO Glucan fibre
WO2014032004A1 (en) 2012-08-24 2014-02-27 Midori Renewables, Inc. Polymeric and solid-supported catalysts, and methods of digesting lignin-containing materials using such catalysts
US9238845B2 (en) 2012-08-24 2016-01-19 Midori Usa, Inc. Methods of producing sugars from biomass feedstocks
KR20150047583A (ko) 2012-08-24 2015-05-04 미도리 리뉴어블즈 인코퍼레이티드 중합체 촉매와 고체-지지된 촉매, 및 이러한 촉매를 사용하여 셀룰로오스 물질을 분해하는 방법
US20150202607A1 (en) 2012-08-24 2015-07-23 Midori Renewables, Inc. Polymeric and solid-supported catalysts, and methods of digesting cellulosic materials using such catalysts
DK2900061T3 (da) * 2012-09-17 2020-03-02 Galectin Therapeutics Inc Fremgangsmåde til forstærkning af specifikke immunterapier ved cancerbehandling
US9045804B2 (en) 2013-01-08 2015-06-02 Wisconsin Alumni Research Foundation Method to produce water-soluble sugars from biomass using solvents containing lactones
EP2769726B1 (en) 2013-02-21 2018-10-31 Jennewein Biotechnologie GmbH Synthetic or recombinant fucosylated Oligosaccarides for use in the treatment of infections
AU2014240435A1 (en) 2013-03-14 2015-09-17 Midori Usa, Inc. Polymeric ionic salt catalysts and methods of producing thereof
EP2983514A4 (en) 2013-03-15 2017-03-15 Cargill, Incorporated Carbohydrate compositions
WO2014142938A1 (en) 2013-03-15 2014-09-18 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
EP2994161B1 (en) * 2013-05-10 2020-10-28 California Institute of Technology Probiotic prevention and treatment of colon cancer
WO2015153841A1 (en) 2014-04-04 2015-10-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
CN104171365A (zh) 2014-07-02 2014-12-03 中泰和（北京）科技发展有限公司 一种提高仔猪断奶重的母猪饲料添加剂及其应用方案
CA3228950A1 (en) 2014-07-09 2016-01-14 Dsm Nutritional Products, Llc Oligosaccharide compositions and methods for producing thereof
DK3354282T3 (da) 2015-01-26 2021-03-08 Kaleido Biosciences Inc Glycan-terapeutiske midler og relaterede fremgangsmåder deraf
BR112017015944B1 (pt) 2015-01-26 2022-03-22 Cadena Bio, Inc Composição de ração animal, pré-mistura de ração animal, uso e método para produzir uma composição de ração animal
WO2016122884A1 (en) 2015-01-26 2016-08-04 Midori Usa, Inc. Oligosaccharide compositions for use as food ingredients and methods of producing thereof
US9492473B2 (en) 2015-01-26 2016-11-15 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
EP3250578A4 (en) 2015-01-26 2018-08-08 Cadena Bio, Inc. Oligosaccharide compositions for use in nutritional compositions, and methods of producing thereof
FR3032709B1 (fr) 2015-02-16 2017-02-24 Roquette Freres Malto-oligo-saccharides riches en fibres et presentant une faible biosdisponibilite en glucose, leur procede de fabrication et leurs utilisations en nutrition humaine et animale
WO2016172658A2 (en) 2015-04-23 2016-10-27 Kaleido Biosciences, Inc. Microbiome regulators and related uses thereof
AU2016253010B2 (en) 2015-04-23 2021-06-10 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
WO2017083520A1 (en) 2015-11-13 2017-05-18 Cadena Bio, Inc. Animal therapeutic and feed compositions and methods of use
EP3551194B1 (en) 2016-12-06 2023-10-18 DSM Nutritional Products, LLC Glycan polymers and related methods thereof
US11484547B2 (en) 2018-01-08 2022-11-01 Performance Labs PTE. LTD. Compositions and methods for cholesterol, glucose and microbiome control

Also Published As

Publication number Publication date
US20190091249A1 (en) 2019-03-28
ES2895725T3 (es) 2022-02-22
JP2021001208A (ja) 2021-01-07
WO2016172657A3 (en) 2016-12-01
DK3285777T3 (da) 2021-08-30
US10894057B2 (en) 2021-01-19
CN116270718A (zh) 2023-06-23
CN107771083A (zh) 2018-03-06
AU2021203398A1 (en) 2021-06-24
US20210401861A1 (en) 2021-12-30
EP3964234A1 (en) 2022-03-09
LT3285777T (lt) 2021-11-25
JP2018517677A (ja) 2018-07-05
US20240108642A1 (en) 2024-04-04
US11883422B2 (en) 2024-01-30
CA2983236A1 (en) 2016-10-27
SI3285777T1 (sl) 2022-02-28
AU2016253010A1 (en) 2017-10-19
AU2016253010B2 (en) 2021-06-10
EP3285777B1 (en) 2021-06-09
US20180147221A1 (en) 2018-05-31
WO2016172657A2 (en) 2016-10-27
EP3285777A2 (en) 2018-02-28

Similar Documents

Publication Publication Date Title
HK1251455A1 (zh) 聚糖治療劑和治療方法
IL277342B (en) Glycan therapy and related methods
IL286316A (en) New micro-dystrophins and related method of use
HUS2400028I1 (hu) PD-1-hez kötõdõ molekulák és alkalmazásukra szolgáló eljárások
HK1252827A1 (zh) 結合lag-3的分子和其使用方法
IL253161B (en) Glycan conjugates and methods for using them
IL282482A (en) Variants of protoxin-II and methods of use
IL282508A (en) Variants of protoxin-II and methods of use
HK1249866A1 (zh) 用他塞利昔布進行治療的方法
GB201511799D0 (en) Composition and methods of treatment
IL255749A (en) Combinations of opioids and acetylamines
GB201621737D0 (en) Compositions and methods of treatment
GB201605127D0 (en) Composition and methods of treatment
GB201417248D0 (en) Compostion and methods of treatment
GB201512139D0 (en) Methods of treatment
GB201503371D0 (en) Methods of screening and treatment
GB201522615D0 (en) Methods of screening and treatment
GB201505437D0 (en) Methods of screening and treatment
GB201503392D0 (en) Methods of screening and treatment
GB201421511D0 (en) Methods of screening and treatment